Congratulations to portfolio company Regenosine on receiving a $1.67M NIH NIAMS Phase II SBIR grant to commercially develop their disease modifying osteoarthritis drug.
Governor Murphy Signs Package of Bills to Support Innovative Businesses in New Jersey
Governor Murphy today signed a three-bill package to help support New Jersey’s thriving innovation ecosystem by enabling entrepreneurs to start...